factual

Bundled Rebates Documented in Restasis and Remicade Suits

Lawsuits are exposing real bundled-rebate exclusion: in October 2017 Shire sued Allergan alleging bundled rebates preserved its dominance in the dry-eye drug Restasis such that a competitor could give its drug away free and still not win, and a late-2017 complaint alleged Johnson & Johnson used a bundling scheme on Remicade weeks after a cheaper biosimilar launched to induce hospitals and plans to exclude the lower-priced copy.

factualpending

Speaker

Robin Feldman

Evidence Quote

“according to one Medicare plan administrator, given Allergan's bundling scheme, the new competitor could give its drug away for free--numbers still wouldn't work.”

Source

Robin Feldman on Drugs, Money, and Secret Handshakes— EconTalk
Created: 6/13/2026, 12:12:41 AM

Your notes

Loading notes...